Antimicrobial Revision in Persistent Febrile Neutropenia

NCT05784844 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was never initiated or activated - Reason was lack of funding

Conditions

Febrile Neutropenia

Interventions

DRUG: Meropenem
DRUG: Micafungin

Sponsor

Wake Forest University Health Sciences